S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.

"all our data are accessible at the gene expression omnibus (geo) repository ( https://www ncbi nlm nih gov/geo ) with the provisional accession series number gse216617.; availability of data and materials transcriptomic data are accessible at the gene expression omnibus (geo) repository ( https://www ncbi nlm nih gov/geo ) with the provisional accession series number gse216617. availability of data and materials transcriptomic data are accessible at the gene expression omnibus (geo) repository ( https://www ncbi nlm nih gov/geo ) with the provisional accession series number gse216617"

"Declarations Ethics approval and consent to participateThe Ethics Committee at the Quebec Heart and Lung Institute which evaluated the project in accordance to “Tri-Council policy statement: ethical conduct for research involving human” and approved the study (CER 22279). Participants were asked for consent to undergo bronchial biopsies and signed an informed consent form. Competing interestsA.C. received: a grant from GSK for an investigator-initiated study; consulting fees from Astra Zeneca; speaker fees from Astra Zeneca, GSK, Valeo pharma, Sanofi and Covis; participation on advisory board for Astras Zeneca, GSK, Valeo pharma, Sanofi and Regeneron. K.G. received: speaker fees from Astra Zeneca, Boehringer, Covis, GSK, Novartis and Valeo pharma; participation on advisory board for Astra Zeneca, Covis, GSK, Sanofi, Valeo pharma and TEVA. Competing interests A.C. received: a grant from GSK for an investigator-initiated study; consulting fees from Astra Zeneca; speaker fees from Astra Zeneca, GSK, Valeo pharma, Sanofi and Covis; participation on advisory board for Astras Zeneca, GSK, Valeo pharma, Sanofi and Regeneron. K.G. received: speaker fees from Astra Zeneca, Boehringer, Covis, GSK, Novartis and Valeo pharma; participation on advisory board for Astra Zeneca, Covis, GSK, Sanofi, Valeo pharma and TEVA."

"Funding P.A.G. received Louise Côté scholarship of Laval University and scholarship complement from Quebec Respiratory Health Research Network (QRHN). M.K. received a scholarship complement from Quebec Respiratory Health Research Network (QRHN). J.C. received grants from Fonds sur les maladies respiratoires J-D-Bégin P-H-Lavoie and Quebec Respiratory Health Research Network (QRHN)."